Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays

H. Versteeg, J. Denollet, M.M. Meine, S.S. Pedersen

Research output: Contribution to journalArticleScientificpeer-review

3 Citations (Scopus)
125 Downloads (Pure)

Abstract

Background
Patient-reported factors have largely been neglected in search of predictors of response to cardiac resynchronisation therapy (CRT). The current study aimed to examine the independent value of pre-implantation patient-reported health status in predicting four-year survival and cardiac-related hospitalisation of CRT patients.
Methods.
Consecutive patients (N = 139) indicated to receive a first-time CRT-defibrillator at the University Medical Center Utrecht were asked to complete a set of questionnaires prior to implantation. The Kansas City Cardiomyopathy Questionnaire (KCCQ) was used to assess heart failure-specific health status. Data on patients' demographic, clinical and psychological characteristics at baseline, and on cardiac-related hospitalisations and all-cause deaths during a median follow-up of 3.9 years were obtained from purpose-designed questionnaires and patients' medical records. Results Results of multivariable Cox regression analyses showed that poor patient-reported health status (KCCQ score
Conclusions.
Patient-reported health status assessed prior to CRT identifies patients at risk for poor survival and prolonged hospital stays, independent of traditional risk factors. These results emphasise the importance of incorporating health status measures in cardiovascular research and patient management. Heart failure patients reporting poor health status should be identified and offered appropriate additional treatment programs.
Original languageEnglish
Pages (from-to)18-24
JournalNetherlands Heart Journal
Volume24
Issue number1
DOIs
Publication statusPublished - 2016

Fingerprint

Dive into the research topics of 'Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays'. Together they form a unique fingerprint.

Cite this